GSEA revealed that 37 of the 50 (74%) cancer stem cell signatures were enriched in the high Mmp10 samples, and that 14 signatures were significantly enriched with a p-value <0.05 and FDR <25% (Table 1). The gene discussed is MMP10; the disease is cancer.